Rare diseases
Investigational molecules
Locations
Back to Italy62 clinical trials in Monserrato, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse
ItalyStudy on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding
ItalyStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
ItalyRandomized Study of SIR9900 for Safety and Effectiveness in Patients with VEXAS Syndrome
ItalyPhase 2 Study of Durvalumab + Tremelimumab with Lenvatinib vs Durvalumab + Tremelimumab Alone in Patients with Unresectable Hepatocellular Carcinoma
ItalyA study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.
ItalyStudy of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy
ItalyStudy on Post-Surgery Treatment for Colon Cancer Patients Using Trifluridine, Irinotecan, and Drug Combination
ItalyStudy on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis
ItalyStudy Comparing Short-Course and Long-Course Chemotherapy with mFOLFIRINOX or PAXG for Patients with Stage I-III Pancreatic Cancer
ItalyStudy of navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
ItalyStudy on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on colorectal cancer, breast cancer, and hepatocellular carcinoma. Studies evaluate novel targeted therapies and combination treatments for both early-stage and metastatic diseases.
Multiple trials exploring innovative approaches to cancer treatment, including biomarker-driven therapies and immunotherapy combinations.
Innovative research in rheumatoid arthritis and ulcerative colitis, investigating new biological therapies and treatment combinations to improve patient outcomes.
Focus on developing precision medicine approaches and understanding biomarker-based treatment responses.
Clinical trials examining new treatments for asthma and interstitial lung disease, with emphasis on innovative delivery systems and targeted therapies.
Studies evaluate both established and novel therapeutic approaches for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
